Title : Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.

Pub. Date : 2022 Jan

PMID : 34688374






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We investigated the efficacy and safety of PD-1 blockade with toripalimab, with or without the COX-2 inhibitor celecoxib, as neoadjuvant treatment for mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancers. Celecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens